No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
GLUE Monte Rosa Therapeutics
- 6.930
- +0.420+6.45%
Close Dec 20 16:00 ET
- 6.930
- 0.0000.00%
Post 16:20 ET
425.76MMarket Cap-3.89P/E (TTM)
7.140High6.410Low2.63MVolume6.440Open6.510Pre Close18.21MTurnover7.12%Turnover RatioLossP/E (Static)61.44MShares12.40052wk High2.07P/B256.10MFloat Cap3.21052wk Low--Dividend TTM36.95MShs Float45.560Historical High--Div YieldTTM11.21%Amplitude2.440Historical Low6.922Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Wells Fargo Downgrades Monte Rosa Therapeutics(GLUE.US) to Hold Rating, Cuts Target Price to $11
Wells Fargo Downgrades Monte Rosa Therapeutics to Equal-Weight, Lowers Price Target to $11
Monte Rosa Therapeutics Analyst Ratings
Press Release: Monte Rosa Therapeutics Appoints Dr. Eric A. Hughes to Board of Directors
Express News | Monte Rosa Therapeutics Appoints DR. Eric a. Hughes to Board of Directors
Monte Rosa Closes Global License Agreement With Novartis
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock the Full List